Clinical Trial Update: Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing sequential administration of CD19 CAR-NK cells followed by 7x19 CAR-T cells in relapsed/refractory B-cell lymphoma, including PMBCL, M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma
• Mediastinal B-cell Lymphoma

Drugs mentioned

• 7x19 CAR-T
• CD19 CAR-NK

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Primary Mediastinal B-cell Lymphoma (PMBCL), Mantle Cell Lymphoma (MCL) | Phase 1 | Status: RECRUITING